NDC 59762-1530-2 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1530
- Requested NDC
- 59762-1530-2
- Package NDCs from labels
- 59762-1530-2
- Manufacturer
- RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited
- Effective date
- 2011-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | 2011-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-1530-1 | EA - Each | 59762-1530 | 33f98858-6344-41d0-b915-1de2df042cb5 | 1 | 2012-07-24 |
| 59762-1530-2 | EA - Each | 59762-1530 | 8a32a6b4-a5fc-43e1-9f0b-8fa4525cb7bb | 1 | 2012-07-24 |
| 59762-1530-3 | EA - Each | 59762-1530 | 870fd041-5725-4d60-b332-1b412ec77377 | 1 | 2012-07-24 |
| 59762-1530-4 | EA - Each | 59762-1530 | 86429126-4c69-4d32-9aff-f6377ab760b9 | 1 | 2012-07-24 |
| 59762-1530-5 | EA - Each | 59762-1530 | b14b19c2-d0b3-4d43-8c7f-14f964865447 | 1 | 2012-07-24 |
| 59762-1530-6 | EA - Each | 59762-1530 | d3aebcb9-4905-4e50-8e8f-34b2e99e96cd | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| anhydrous dibasic calcium phosphate | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | dc2107cd-edfa-44a6-b139-edee6ccf47ce | 2025-04-08 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | A-S Medication Solutions | 00a037f6-b17f-4d21-9a9a-0e682f68d483 | 2025-04-02 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Camber Pharmaceuticals, Inc. | 99865c67-5475-4e60-98d5-a8fa850fe9ba | 2025-03-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 313fe7ba-2fbd-bb4d-e063-6294a90a3749 | 2025-03-26 | Warnings, Adverse reactions | 197361 864V2Q084H |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 1dd12925-ede8-4ad5-9309-d8c79da1cebf | 2025-02-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE AND VALSARTAN | AMLODIPINE AND VALSARTAN | Cadila Pharmaceuticals Limited | 97be7df1-143e-4bff-aed3-2b9ec11d30b3 | 2025-02-18 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Proficient Rx LP | 6313edc5-d2d5-44a1-a06f-7f7829c870d2 | 2025-02-01 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Redpharm Drug | fc61eee9-ee15-9078-e053-6394a90a22f4 | 2025-01-23 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | DIRECT RX | b8b9a3cd-c4e7-dfeb-e053-2a95a90aa719 | 2025-01-17 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | NCS HealthCare of KY, LLC dba Vangard Labs | 47f228e9-4a34-4d14-988d-b06af90124b9 | 2025-01-16 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 7c75fa72-9b0f-44bf-a745-dfa647ed1e78 | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| amlodipine,valsartan and hydrochlorothiazide | AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 1ea4f227-b97a-49f1-bbc3-1dede2c1866d | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Micro Labs Limited | 7fcf6a87-7b3e-4cef-8c47-c8a008cfea82 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 1871ddaf-ed2c-c3ce-e063-6394a90a1bee | 2024-12-20 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Quality Care Products, LLC | a75e4797-6b7f-4366-9105-79d6877adac5 | 2024-12-19 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Quality Care Products, LLC | 6b7c18ef-3a85-4ae3-9135-7ac30a0dde08 | 2024-12-17 | Warnings, Adverse reactions | 197361 864V2Q084H |
| amlodipine besylate | AMLODIPINE BESYLATE | Mylan Pharmaceuticals Inc. | 180ee374-24f2-4b9c-9d54-8815f2b1dc9b | 2024-11-28 | Warnings, Adverse reactions | NDA019787 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Zydus Lifesciences Limited | cacb3551-c579-41cb-bed6-4b4d8b0644fc | 2024-11-25 | 197361 864V2Q084H | |
| Amlodipine and atorvastatin | AMLODIPINE AND ATORVASTATIN | Mylan Pharmaceuticals Inc. | 4be76756-4114-4d50-a36c-fd410f6c773d | 2024-11-11 | Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.